These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34931905)

  • 1. Challenges and Opportunities for Nucleic Acid Therapeutics.
    Corey DR; Damha MJ; Manoharan M
    Nucleic Acid Ther; 2022 Feb; 32(1):8-13. PubMed ID: 34931905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
    Gait MJ; Agrawal S
    Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases.
    Holm A; Hansen SN; Klitgaard H; Kauppinen S
    RNA Biol; 2022; 19(1):594-608. PubMed ID: 35482908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent progress and prospect in oligonucleotide therapeutics].
    Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
    Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The infinite possibilities of RNA therapeutics.
    Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.
    Niemietz C; Chandhok G; Schmidt H
    Molecules; 2015 Sep; 20(10):17944-75. PubMed ID: 26437390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
    Vetter VC; Wagner E
    J Control Release; 2022 Jun; 346():110-135. PubMed ID: 35436520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies.
    Taniguchi H; Suzuki Y; Imai K; Adachi Y
    Cancer Sci; 2022 Sep; 113(9):2952-2961. PubMed ID: 35701833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA therapeutics for metabolic disorders.
    Vu TD; Lin SC; Wu CC; Chu DT
    Prog Mol Biol Transl Sci; 2024; 203():181-196. PubMed ID: 38359998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA therapeutics: updates and future potential.
    Zhang C; Zhang B
    Sci China Life Sci; 2023 Jan; 66(1):12-30. PubMed ID: 36100838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Types of RNA therapeutics.
    Goleij P; Babamohamadi M; Rezaee A; Sanaye PM; Tabari MAK; Sadreddini S; Arefnezhad R; Motedayyen H
    Prog Mol Biol Transl Sci; 2024; 203():41-63. PubMed ID: 38360005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.
    Cha W; Fan R; Miao Y; Zhou Y; Qin C; Shan X; Wan X; Li J
    Molecules; 2017 May; 22(5):. PubMed ID: 28492505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects.
    Vaillant A
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress on RNA-based therapeutics for genetic diseases.
    Luo T; Huo C; Zhou T; Xie S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid delivery for therapeutic applications.
    Gupta A; Andresen JL; Manan RS; Langer R
    Adv Drug Deliv Rev; 2021 Nov; 178():113834. PubMed ID: 34492233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment.
    Yamakawa K; Nakano-Narusawa Y; Hashimoto N; Yokohira M; Matsuda Y
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs.
    Gagnon KT; Corey DR
    Nucleic Acid Ther; 2019 Jun; 29(3):116-122. PubMed ID: 30907681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A status update of modified oligonucleotides for chemotherapeutics applications.
    Sanghvi YS
    Curr Protoc Nucleic Acid Chem; 2011 Sep; Chapter 4():Unit 4.1.1-22. PubMed ID: 21901670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.